These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2972068)

  • 1. Radionuclide evaluation of renal transplants.
    Dubovsky EV; Russell CD
    Semin Nucl Med; 1988 Jul; 18(3):181-98. PubMed ID: 2972068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
    Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
    Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MAG3, a new renal imaging agent: preliminary results in patients.
    Taylor A; Eshima D; Alazraki N
    Eur J Nucl Med; 1987; 12(10):510-4. PubMed ID: 2952506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine).
    Bubeck B; Brandau W; Steinbächer M; Reinbold F; Dreikorn K; Eisenhut M; Georgi P
    Int J Rad Appl Instrum B; 1988; 15(1):109-18. PubMed ID: 2965116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA.
    Al-Nahhas AA; Jafri RA; Britton KE; Solanki K; Bomanji J; Mather S; Carroll MA; Al-Janabi M; Frusciante V; Ajdinowic B
    Eur J Nucl Med; 1988; 14(9-10):453-62. PubMed ID: 2975219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
    Taylor A; Ziffer JA; Eshima D
    Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
    Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
    Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
    [No Abstract]   [Full Text] [Related]  

  • 11. Tc-99m DTPA dynamic renal scintigraphy in the evaluation of renal transplants: the importance of perfusion index in the diagnosis of renal allograft rejection.
    Siraj QH; Inam-ur-Rehman A; Waqar A; Shah MH; Ahmed RI; Sadiq M; Burney R; Ahmed SA
    J Pak Med Assoc; 1988 May; 38(5):139-48. PubMed ID: 3146658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Isotopic studies in renal transplantation].
    Levasseur A; Robillard R; Lemieux R; Dandavino R; Girard R
    Union Med Can; 1981 May; 110(5):454-62. PubMed ID: 7020202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parametric representation of kidney function using 99mTc-mercaptoacetyltriglycine (MAG3)].
    Szabó Z; Kutkuhn B; Georgescu G; Mecklenbeck W; Suatmadji A; Vosberg H
    Nuklearmedizin; 1989 Jun; 28(3):73-83. PubMed ID: 2525703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-2,3-diaminopropionic acid complex as renal function agent: comparison of biological properties with 99mTc-DTPA and 131I-OIH.
    Chattopadhyay M; Jalan KN; Pal AK; Banerjee SN
    Int J Rad Appl Instrum B; 1987; 14(6):599-604. PubMed ID: 3323136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The differential use of 99mTc-DTPA and 99mTc-MAG3 in the aftercare of kidney transplant patients].
    Kotzerke J; Burchert W; Ringe B; Hundeshagen H
    Rofo; 1990 Feb; 152(2):241-2. PubMed ID: 2155467
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of renal scintigram with 125I-OIH and 99mTc-DTPA in renal transplantation].
    Ishibashi A; Fujino A; Ikeda S; Ishii K; Nakazawa K; Watanabe T; Suzuki J; Yoda K
    Kaku Igaku; 1983 Feb; 20(1):45-52. PubMed ID: 6348355
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
    Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
    Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.